vs
Hello Group Inc.（MOMO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Hello Group Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.8倍（$368.3M vs $207.3M），Hello Group Inc.净利率更高（9.2% vs -62.0%，领先71.3%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -63.8%）
Hello Sunshine是一家美国传媒公司，由女演员瑞茜·威瑟斯彭与Strand Equity创始人兼执行合伙人赛斯·罗德斯基于2016年共同创立，主营业务涵盖影视内容开发制作、女性向IP运营等传媒相关业务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
MOMO vs RARE — 直观对比
营收规模更大
MOMO
是对方的1.8倍
$207.3M
净利率更高
MOMO
高出71.3%
-62.0%
两年增速更快
RARE
近两年复合增速
-63.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $368.3M | $207.3M |
| 净利润 | $34.0M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -54.7% |
| 净利率 | 9.2% | -62.0% |
| 营收同比 | — | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | — | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MOMORARE
| Q1 26 | $368.3M | — | ||
| Q4 25 | — | $207.3M | ||
| Q3 25 | $372.3M | $159.9M | ||
| Q2 25 | $365.8M | $166.5M | ||
| Q1 25 | — | $139.3M | ||
| Q4 24 | — | $164.6M | ||
| Q3 24 | $381.1M | $139.5M | ||
| Q2 24 | $2.5B | $147.0M |
净利润MOMORARE
| Q1 26 | $34.0M | — | ||
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $49.1M | $-180.4M | ||
| Q2 25 | $-19.5M | $-115.0M | ||
| Q1 25 | — | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $64.0M | $-133.5M | ||
| Q2 24 | $54.7M | $-131.6M |
毛利率MOMORARE
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 38.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 39.3% | — | ||
| Q2 24 | 39.3% | — |
营业利润率MOMORARE
| Q1 26 | — | — | ||
| Q4 25 | — | -54.7% | ||
| Q3 25 | 13.0% | -106.9% | ||
| Q2 25 | 15.4% | -64.8% | ||
| Q1 25 | — | -102.6% | ||
| Q4 24 | — | -74.3% | ||
| Q3 24 | 15.4% | -94.6% | ||
| Q2 24 | 26.3% | -79.1% |
净利率MOMORARE
| Q1 26 | 9.2% | — | ||
| Q4 25 | — | -62.0% | ||
| Q3 25 | 13.2% | -112.8% | ||
| Q2 25 | -5.3% | -69.0% | ||
| Q1 25 | — | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | 16.8% | -95.7% | ||
| Q2 24 | 2.2% | -89.5% |
每股收益（稀释后）MOMORARE
| Q1 26 | — | — | ||
| Q4 25 | — | $-1.28 | ||
| Q3 25 | — | $-1.81 | ||
| Q2 25 | — | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | — | $-1.34 | ||
| Q3 24 | — | $-1.40 | ||
| Q2 24 | — | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $760.8M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $-80.0M |
| 总资产 | $2.0B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MOMORARE
| Q1 26 | $760.8M | — | ||
| Q4 25 | — | $421.0M | ||
| Q3 25 | $588.9M | $202.5M | ||
| Q2 25 | $700.4M | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | $470.4M | $150.6M | ||
| Q2 24 | $819.9M | $480.7M |
股东权益MOMORARE
| Q1 26 | — | — | ||
| Q4 25 | — | $-80.0M | ||
| Q3 25 | — | $9.2M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | — | $144.2M | ||
| Q4 24 | — | $255.0M | ||
| Q3 24 | — | $346.8M | ||
| Q2 24 | — | $432.4M |
总资产MOMORARE
| Q1 26 | $2.0B | — | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.9B | $1.2B | ||
| Q2 25 | $2.3B | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $2.6B | $1.5B | ||
| Q2 24 | $2.4B | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流MOMORARE
| Q1 26 | — | — | ||
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $20.2M | $-91.4M | ||
| Q2 25 | $34.9M | $-108.3M | ||
| Q1 25 | — | $-166.5M | ||
| Q4 24 | — | $-79.3M | ||
| Q3 24 | — | $-67.0M | ||
| Q2 24 | $65.4M | $-77.0M |
自由现金流MOMORARE
| Q1 26 | — | — | ||
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $3.5M | $-92.7M | ||
| Q2 25 | $31.3M | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | $37.9M | $-79.0M |
自由现金流率MOMORARE
| Q1 26 | — | — | ||
| Q4 25 | — | -48.6% | ||
| Q3 25 | 1.0% | -58.0% | ||
| Q2 25 | 8.5% | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | 1.5% | -53.7% |
资本支出强度MOMORARE
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | 4.5% | 0.8% | ||
| Q2 25 | 1.0% | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | 1.1% | 1.4% |
现金转化率MOMORARE
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.19× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MOMO
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
